Partial amino-terminal sequence analysis was performed on radiolabeled poliovirus capsid proteins VP1, VP2, and VP3. A computer-assisted comparison of the amino acid sequences obtained with that predicted by the nucleotide sequence of the poliovirus genome allows assignment of the amino terminus of each capsid protein to a unique position within the virus polyprotein. Sequence analysis of trypsin-digested VP4, which has a blocked amino terminus, demonstrates that VP4 is encoded at or very near to the amino terminus of the polyprotein. The gene order of the capsid proteins is VP4-VP2-VP3-VP1. Cleavage of VPO to VP4 and VP2 is shown to occur between asparagine and serine, whereas the cleavages that separate VP2/VP3 and VP3/VP1 occur between glutamine and glycine residues. This finding supports the hypothesis that the cleavage of VP0, which occurs during virion morphogenesis, is distinct from the cleavages that separate functional regions of the polyprotein.
All picornaviruses are nonenveloped, icosahedral virions consisting of a plus-strand RNA genome surrounded by approximately 60 molecules each of four virus-coded capsid proteins. These capsid proteins serve to protect the RNA genome as well as to interact with specific hostcell surface receptors during virus adsorption. The capsid proteins also elicit an antigenic response in the host animal that may limit virus infection and protect the host. Because capsid proteins play such crucial roles in the virus life cycle, their structure is of particular interest to both molecular and medical virologists.
Expression of the polio viral genome results in the synthesis of a polyprotein, NCVP0O (247,000 molecular weight [MW] ), which is cleaved during translation into at least 12 major polypeptides (8, 10, 21) . The initial proteolytic products, P1-la (NCVPla), P2-3b (NCVP3b), and P3-lb (NCVPlb), correspond to three regions of the genome, designated P1, P2, and P3, respectively (see Fig. 4 ). The four major capsid proteins of poliovirus, VPl (33,500 MW), VP2 (30,000 MW), VP3 (26,400 MW), and VP4 (7,400 MW), are the final proteolytic products of the precursor P1-la (97,000 MW). Pactamycin mapping has positioned P1-la at the amino terminus of NCVPOO (22, 23) , and a similar method was used to determine the gene order of the capsid proteins as (NH2)-VP4-VP2-VP3-VP1 (17) . In addition to the major structural proteins, virions usually contain a few copies of VPO (37,300 MW), the immediate precursor to VP4 and VP2 (9) . Cleavage of VPO has been shown to be associated with virion morphogenesis (11) .
To determine the primary structure of each capsid protein and to identify the precise sites for proteolytic processing, we have obtained partial amino acid sequence information for each of the capsid proteins of Mahoney type I poliovirus. Virion proteins were labeled in vivo with several 3H-amino acids, one at a time, or with [35S]methionine. Purified virus was then directly subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. This method did not produce doublets of viral proteins, as reported by others (24) . Sequencing was accomplished by the application of the purified virion proteins to a Beckman 890C protein sequencer (4, 20) . The partial amino acid sequence obtained was then compared with that predicted by the recently completed nucleotide sequence of the poliovirus genome (12) .
Representative results from microsequencing experiments on VP1, VP2, and VP3 are shown in Fig. 1 . For VP1, radioactivity from [35S]methionine was found in residues 5 and 9 and radioactivity from [3H]glycine was found in residues 1, 3, and 19. When the translated sequence of the poliovirus genome (12) was searched for this arrangement of amino acids, only one possible encoding location was found. This analysis places the first nucleotide encoding the aminoterminal glycine of VP1 at 2,475 nucleotides from the 5' end of the genome (Fig. 2 (1, 20 (12) .
[3H]alanine-labeled VP3 indicated that glycine was the 1st and 9th residue, whereas alanine was found to be the 16th residue (Fig. 1 (12) .
Sequence analysis of VP2 was performed in a similar manner. As shown in Fig. 1 , leucine was found to be the 14th, 16th, and 18th residues, whereas the 1st, 10th, and 21st residues were found to be serine. Computer analysis places the codon of the amino-terminal residue of VP2 at nucleotide 948 (Fig. 2) . In support of this conclusion, tyrosine was found to be the 9th residue, isoleucine the 4th and 23rd residues, and glycine the 8th residue (data not shown).
Amino-terminal sequence analysis cannot be used to locate the genomic encoding location of VP4 because it has a blocked amino terminus (17, 22 quence analysis of the mixed tryptic peptides of purified VP4. This technique has previously been used to identify peptides within bacteriophage MS2 proteins (2). Tyrosine was found to be the 2nd, 9th, 14th, and 15th residues of the peptides produced by trypsin digestion (Fig. 3) . Analysis of undigested tyrosine-labeled VP4 failed to yield significant radioactivity at any residue, as expected (data not shown). Inspection of the nucleotide sequence reveals that four tyrosine residues are predicted to occur in the long open reading frame of the polyprotein to the 5' side of the amino terminus of VP2 (Fig. 2) . The sequencing data agree with this predicted arrangement of tyrosine residues within the single tryptic peptide encoded by nucleotides 795 to 842 (Fig. 2) . No other tyrosine-containing tryptic peptides of VP4 have been found by reversephase chromatographic analysis (unpublished data). Additional evidence confirming the amino acid composition of this tryptic peptide was obtained by sequence analysis of a tryptic digest of [3H]isoleucine-labeled VP4 which indicated that isoleucine is the 7th and 12th residue of the tyrosine-containing tryptic peptide (data not shown).
In agreement with previous pactamycin mapping experiments (17) , the data presented in Fig.   2 show that VP4 maps in the open reading frame to the 5' side of the amino terminus of VP2. We have not yet determined the exact encoding location for the amino terminus of VP4; however, a consideration of its reported molecular weight, 8,000 Mr (19) , its reported lack of cysteine residues (18, 25) , and the location of the first methionine codon in the long, open reading frame of poliovirus RNA leads us to suggest that the amino terminus of VP4 may be encoded at nucleotide 744, a position 68 amino acids to the 5' side of the amino terminus of VP2 (for a discussion, see reference 12). Experiments to directly identify the amino terminus of VP4 as well as the initiation site for synthesis of the polyprotein are in progress.
We have provided direct evidence that the amino-terminal amino acid residues of VP2, VP3, and VP1 are serine, glycine, and glycine, respectively ( Fig. 1 and 2) . The complete nucleotide sequence of poliovirus RNA (12) allows us also to predict the amino acid residue that precedes each of these amino-terminal amino acids. Hence we can predict the amino acid pair in the precursor polypeptide(s) in which cleavage occurs to generate the carboxy terminus of one protein and the amino terminus of the adjacent protein. A comparison of these cleavage sites for the capsid proteins of poliovirus (from Fig. 2 ) and other picornaviruses studied, mengovirus (26) and aphthovirus (3, 5) , is shown in Table 1 . Although no obvious consensus of cleaved amino acid pairs can be derived from Table 1, glutamine is the predominant amino acid found at the carboxy-terminal position, and glycine is the most frequent amino acid present at the amino-terminal position. For poliovirus, the VP2/VP3 cleavage and the VP3NVP1 cleavage both occur at Gln-Gly amino acid pairs. Recent reports (20, 20a) have shown that cleavage between glutamine and glycine occurs in the precursor polypeptides to produce most of the P2 and P3 region protein products in poliovirusinfected HeLa cells. These findings show that proteolytic processing of poliovirus precursors occurs predominantly at Gln-Gly amino acid pairs and suggest that a single proteinase may be responsible for these cleavages. Although the Gln-Gly sequence must be an important part of the proteolytic specificity, we assume that other recognition factors are involved since no significant degradation of cellular proteins occurs during the first 4 h of a poliovirus infection (14) . In addition, a few Gln-Gly pairs are located within the poliovirus polyprotein for which we have not yet found corresponding cleavage products.
One notable exception to the processing of poliovirus proteins at Gln-Gly pairs is the proteolytic cleavage of VPO that generates the protein products VP4 and VP2. This cleavage is predicted to occur at an Asn-Ser dipeptide in VPO and appears to be concomitant with viral RNA association with procapsid structures, the precursors to mature virions. Procapsids have been shown to contain only three proteins, VPO, VP1, and VP3 (11) . For a detailed review of picornaviral assembly, refer to a recent article by Putnak and Phillips (16) . Furthermore, in vitro processing of P1-la using infected cytoplasmic extracts produced the polypeptide products VPO, VP1, and VP3 (13) . Thus without capsid assembly, either in vitro or in vivo, there is no conversion of VPO to VP4 and VP2. This result implies that association with viral RNA induces a conformational alteration of the procapsid, rendering VPO sensitive to proteinase. Since the VPO cleavage site does not conform with the predicted Gln-Gly specificity of the proteinase that produces most viral proteins, the possibility exists that another proteinase (either viral or cellular) is responsible for this cleavage. Interestingly, proteinase activity in highly purified virus preparations has been reported for poliovirus (7) and encephalomyocarditis virus (15) . Figure 4 shows the three major coding regions (P1, P2, and P3) of the viral genome and summarizes the results presented in this paper for the products encoded by the P1 region. The placement of protein P1-3a in this scheme as an intermediate precursor to VPO and VP3 is based on the data of Butterworth (6) and our own preliminary evidence that P1-3a is blocked at its amino terminus (unpublished). The molecular weights of the capsid proteins are calculated from our sequencing data on the assumption that no carboxy-terminal trimming occurs. These values are in close agreement with previous estimates (6, 19 
